Endo Int'l (NASDAQ: ENDP) reported Q4 EPS of $1.36, $0.09 better than the analyst estimate of $1.27. Revenue for the quarter came in at $1.07 billion versus the consensus estimate of $1.07 billion.

GUIDANCE:

Endo Int'l sees FY2016 EPS of $5.85-$6.20, versus the consensus of $6.02.

For earnings history and earnings-related data on Endo Int'l (ENDP) click here.